| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |